Abstract
This study was planned as an open-label, single-centre trial with blinded evaluations by two independent radiologists, aimed at the intra-individual comparison of single-dose and double-dose Gd-DTPA-enhanced MRA in the renal arterial territory. Ten healthy volunteers were included in the study. Renal MRAs were carried out on a clinical 1.5-T MR system using a body phased-array coil. Images were acquired with three-dimensional fast spoiled gradient echo sequence. Contrast agent was injected with a power injector keeping the injection time constant for single dose and double dose. Both readers found at least 96% of vascular segments evaluable. Median overall image quality was rated excellent, and diagnostic confidence was rated confident. No statistically significant difference between the dosage groups could be demonstrated. Signal intensity, SNR and CNR were significantly higher for the double-dose group. Our results demonstrate that while a double dose of contrast agent increases SNR, it does not lead to further improvement in visual and perceptual image quality. A single dosage of approximately 0.1 mmol/kg bw Gd-DTPA may be the preferable dosage to demonstrate the renal arteries.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Leiner T, de Haan MW, Nelemans PJ et al (2005) Contemporary imaging techniques for the diagnosis of renal artery stenosis. Eur Radiol 15:2219–2229
Waugh JR, Sacharias N (1992) Arteriographic complications in the DSA era. Radiology 182:243–246
Young N, Chi KK, Ajaka J et al (2002) Complications with outpatient angiography and interventional procedures. Cardiovasc Intervent Radiol 25:123–126
Cochran ST, Bomyea K, Sayre JW (2001) Trends in adverse events after IV administration of contrast media. AJR Am J Roentgenol 176:1385–1388
Dumoulin CL, Hart HR Jr. (1986) Magnetic resonance angiography. Radiology 161:717–720
Edelman RR, Zhao B, Liu C et al (1989) MR angiography and dynamic flow evaluation of the portal venous system. AJR Am J Roentgenol 153:755–760
Grist TM (2000) MRA of the abdominal aorta and lower extremities. J Magn Reson Imaging 11:32–43
Yucel EK, Anderson CM, Edelman RR et al (1999) AHA scientific statement. Magnetic resonance angiography: update on applications for extracranial arteries. Circulation 100:2284–2301
van Helvoort-Postulart D, Dirksen CD, Kroon AA et al (2006) Cost analysis of procedures related to the management of renal artery stenosis from various perspectives. Eur Radiol 16:154–160
Thomsen HS (2006) Nephrogenic systemic fibrosis: A serious late adverse reaction to gadodiamide. Eur Radiol 16:2619–2621
Heverhagen JT (2007) Noise measurement and estimation in MR imaging experiments. Radiology 245:638–639
Frayne R, Grist TM, Swan JS et al (2000) 3D MR DSA: effects of injection protocol and image masking. J Magn Reson Imaging 12:476–487
Heverhagen JT, Funck RC, Schwarz U et al (2001) Kinetic evaluation of an i.v. bolus of MR contrast media. Magn Reson Imaging 19:1025–1030
Heverhagen JT, Reitz I, Pavlicova M et al (2007) The impact of the dosage of intravenous gadolinium-chelates on the vascular signal intensity in MR angiography. Eur Radiol 17:626–637
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Heverhagen, J.T., Wright, C.L., Schmalbrock, P. et al. Dose comparison of single versus double dose in contrast-enhanced magnetic resonance angiography of the renal arteries: intra-individual cross-over blinded trial using Gd-DTPA. Eur Radiol 19, 67–72 (2009). https://doi.org/10.1007/s00330-008-1120-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00330-008-1120-9